Trials / Completed
CompletedNCT03532854
Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802
A Randomized, Open-label, Multiple-dose, Crossover Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic Drug-drug Interaction Between LGEV1801 and LGEV1802 in Healthy Korean Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the drug-drug interaction between LGEV1801 and LGEV1802 in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan | Valsartan P.O |
| DRUG | Ezetimibe/Rosuvastatin | Ezetimibe/Rosuvastatin P.O |
Timeline
- Start date
- 2018-05-28
- Primary completion
- 2018-08-25
- Completion
- 2019-01-30
- First posted
- 2018-05-22
- Last updated
- 2019-02-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03532854. Inclusion in this directory is not an endorsement.